Trivium Point Advisory LLC Lowers Position in CME Group Inc. (NASDAQ:CME)

Trivium Point Advisory LLC lessened its position in CME Group Inc. (NASDAQ:CME) by 15.4% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 12,930 shares of the financial services provider’s stock after selling 2,360 shares during the quarter. Trivium Point Advisory LLC’s holdings in CME Group were worth $3,430,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in CME. Vanguard Group Inc. raised its stake in CME Group by 1.2% during the first quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider’s stock valued at $9,190,661,000 after buying an additional 400,737 shares during the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of CME Group by 89.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider’s stock worth $1,923,047,000 after purchasing an additional 3,921,278 shares during the last quarter. Northern Trust Corp raised its stake in shares of CME Group by 11.4% in the fourth quarter. Northern Trust Corp now owns 3,943,454 shares of the financial services provider’s stock worth $915,788,000 after purchasing an additional 403,920 shares during the last quarter. Janus Henderson Group PLC raised its stake in shares of CME Group by 24.7% in the fourth quarter. Janus Henderson Group PLC now owns 3,135,753 shares of the financial services provider’s stock worth $728,260,000 after purchasing an additional 621,713 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA grew its holdings in shares of CME Group by 29.9% in the first quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider’s stock worth $747,744,000 after acquiring an additional 648,591 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

NASDAQ:CME opened at $273.92 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market capitalization of $98.72 billion, a P/E ratio of 26.52, a P/E/G ratio of 4.89 and a beta of 0.44. CME Group Inc. has a 12 month low of $204.16 and a 12 month high of $290.79. The business’s 50-day moving average is $275.53 and its 200 day moving average is $266.60.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the previous year, the business earned $2.56 earnings per share. On average, equities research analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be given a dividend of $1.25 per share. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. CME Group’s dividend payout ratio is 48.40%.

Insider Buying and Selling at CME Group

In other CME Group news, Director Charles P. Carey sold 500 shares of the company’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $265.35, for a total transaction of $132,675.00. Following the sale, the director directly owned 4,900 shares in the company, valued at $1,300,215. This represents a 9.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director William R. Shepard purchased 256 shares of CME Group stock in a transaction dated Wednesday, June 25th. The stock was acquired at an average price of $270.53 per share, for a total transaction of $69,255.68. Following the completion of the acquisition, the director owned 258,196 shares of the company’s stock, valued at approximately $69,849,763.88. This trade represents a 0.10% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders sold 2,450 shares of company stock valued at $676,663. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on CME. Morgan Stanley lifted their price objective on CME Group from $301.00 to $304.00 and gave the stock an “overweight” rating in a report on Thursday, April 24th. Keefe, Bruyette & Woods boosted their price target on CME Group from $265.00 to $273.00 and gave the company a “market perform” rating in a report on Thursday, April 24th. Erste Group Bank lowered CME Group from a “strong-buy” rating to a “hold” rating in a report on Saturday, May 24th. UBS Group reissued a “neutral” rating and set a $305.00 price target on shares of CME Group in a report on Thursday, July 24th. Finally, Barclays set a $298.00 price target on CME Group and gave the company an “equal weight” rating in a report on Thursday, July 24th. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $261.93.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.